Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GS.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.55.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.55.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.55.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LQ.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LQ.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LQ.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.62NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.62NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.55NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDKNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDKNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDKNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.54NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.120 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.120 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.120 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDK.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDK.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LL.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used